Palatin Technologies Inc. (PTN)

AMEX: PTN · Real-Time Price · USD

0.22

0.02 (10.00%)

At close: May 01, 2025, 3:52 PM

10.00% (1D)

Bid	0.22
Market Cap	6.18M
Revenue (ttm)	350K
Net Income (ttm)	-26.95M
EPS (ttm)	-1.54
PE Ratio (ttm)	-0.14
Forward PE	0.1
Analyst	Buy

Ask	0.22
Volume	1,166,501
Avg. Volume (20D)	2,709,660
Open	0.19
Previous Close	0.20
Day's Range	0.19 - 0.22
52-Week Range	0.16 - 2.48
Beta	0.90

About PTN

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen...

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Oct 15, 1997

Employees 30

Stock Exchange AMEX

Ticker Symbol PTN

Website https://palatin.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PTN stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 3086.16% from the latest price.

Stock Forecasts

Why Price Moved

2 weeks ago

-4.46%

Palatin Technologies shares are trading lower afte... Unlock content with Pro Subscription

2 months ago

+14.32%

Palatin Technologies shares are trading higher after the company announced the completion of its Phase 2 BMT-801 clinical study of MC4R.

News

3 weeks ago · businesswire.com

NYSE American to Commence Delisting Proceedings Against Palatin Technologies, Inc. (PTN)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of ...

2 months ago · seekingalpha.com

Palatin Technologies, Inc. (PTN) Q2 2025 Earnings Call Transcript

Palatin Technologies, Inc. (NYSE:PTN ) Q2 2025 Earnings Conference Call February 13, 2024 11:00 AM ET Company Participants Carl Spana - CEO and President Stephen Wills - CFO, COO, Treasurer and Secret...